Camil Diaz

Camil Diaz is a Principal Scientist at Genentech.  She joined the Media and Process Group in 2019, helping advance the globally aligned CHO cell culture platform currently in use for all new molecular entities at Genentech and Roche.  She obtained her B.S. in Chemical Engineering from Stanford University in 2013 and her Ph.D. in Chemical and Biomolecular Engineering from the University of Delaware in 2019, training in the labs of Elizabeth Sattely and Maciek Antoniewicz, respectively.  Her graduate work centered on the use of ¹³C-metabolic flux analysis as a tool for modeling and characterizing the core metabolism of an aerobic diazotroph.  Her current interests are in mammalian metabolism, redox chemistry, and medium stability.